Enhanced anti-tumor effects through continuous administration of engineered CAR-macrophages derived from pluripotent stem cell-derived myeloid celllines.
Yuya Atsumi, Akira Niwa, Tatsuro Kumaki, Shigeki Yagyu, Yozo Nakazawa, Megumu K. Saito
This study develops CAR-macrophages from pluripotent stem cell-derived myeloid cell lines for enhanced anti-tumor effects through repeated administration.
bioRxiv · Jul 22, 2024 · PreprintBioengineering